Impact Factor

2.6

Global Health & Medicine -> 2022 Vol.4(No.4)

Review
Evaluation of the representativeness of data in the COVID-19 Registry Japan during the first six waves of the epidemic
Global Health & Medicine. 2022; 4(4):204-209.
The patient-centered diabetes management during the COVID-19 pandemic
Global Health & Medicine. 2022; 4(4):210-215.
Original Article
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferonbased therapy
Global Health & Medicine. 2022; 4(4):216-224.
Brief Report
Closure and anastomosis of the pancreas using a four-needle threeloop suture device
Global Health & Medicine. 2022; 4(4):225-229.
Correspondence
Actual situation of handling Tokyo 2020 Games-related patients at a designated hospital during COVID-19 pandemic
Global Health & Medicine. 2022; 4(4):230-232.
A novel anticoagulation treatment protocol using unfractionated heparin for coronavirus disease 2019 patients in Japan, 2022
Global Health & Medicine. 2022; 4(4):233-236.
The role of radiologic technologists during the COVID-19 pandemic
Global Health & Medicine. 2022; 4(4):237-241.
Perspective
Adapting pediatric health care responses to the COVID-19 pandemic in Japan: A clinical perspective
Global Health & Medicine. 2022; 4(4):242-246.
Letter
Boosting multiregional clinical trials (MRCT) in Asia through the establishment of the Japan-led network for clinical research, the ARO alliance for ASEAN & East Asia (ARISE)
Global Health & Medicine. 2022; 4(4):247-249.
International technical cooperation to low- and middle-income countries during the COVID-19 pandemic
Global Health & Medicine. 2022; 4(4):250-252.